AS

Addanki Subbaiah Arunachalam Setty

Active Director Director DIN 00789596
DIN 00789596 First appointment May 2004
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Addanki Subbaiah Arunachalam Setty

Data last updated:

Addanki Subbaiah Arunachalam Setty is a Director at Vepra Health Care And Research Private Limited (since 2004).

DIN 00789596
Primary Designation Director
First Appointment 12 May 2004
Oldest Company Age 22 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 May 20042004Active

Board colleagues of Addanki Subbaiah Arunachalam Setty

Directorship timeline

Open interactive timeline →
Vepra Health Care And Research Private Limited
Premium access

Shareholding and investment profile for Addanki Subbaiah Arunachalam Setty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Addanki Subbaiah Arunachalam Setty

Addanki Subbaiah Arunachalam Setty currently holds 1 directorship: Vepra Health Care And Research Private Limited (Director, since 12 May 2004).

Addanki Subbaiah Arunachalam Setty was first appointed on 12 May 2004 as Director at Vepra Health Care And Research Private Limited.

The current boards of Addanki Subbaiah Arunachalam Setty's companies include Addanki Chandrashekhar (Vepra Health Care And Research Private Limited), Addanki Venkatavara Prasad (Vepra Health Care And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available